CTBC Bank USA CEO Noor Menai to Speak in Dual Role at

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
680
CTBC Bank USA CEO Noor Menai to Speak in Dual Role at Economist Events’ Finance Disrupted Conference

NEW YORK, Sept. 25, 2017 (GLOBE NEWSWIRE) -- CTBC Bank USA announced today that its President & CEO  Noor Menai will speak this week at the Economist Events' Finance Disrupted conference on Thursday at Convene event center in New York. 

Menai will first speak on the “Risk and the New Regulatory Agenda” panel, which will focus on expected changes driven by the Trump administration’s deregulatory agenda as well as how technology could improve the way both regulators and compliance divisions at financial institutions do their jobs. The panel will be moderated by Vijay Vaitheeswaran , The Economist’s U.S. Business Editor.

In addition, Menai will participate in an Oxford-style debate on whether Alibaba, Amazon, Apple, Facebook and Google are a bigger challenge to traditional banks than any fintech startup. Mr. Menai, partnering with Arun Sundararajan, author of The Sharing Economy, will argue that the tech giants are a bigger adversary to banks.

In the debate, arguing on behalf of the fintechs will be David Golden, Managing Partner of Revolution Ventures and Kathryn Petralia, Co-Founder of Kabbage. The debate will also be moderated by The Economist’s Vaitheeswaran.

Background on Mr. Menai’s and other speakers’ insights are available in the Economist Events' pre-conference interviews .

The conference will cover the latest developments in the world of disruptive financial technology, and will specifically tackle topics such as artificial intelligence, cybersecurity and fraud, blockchain, regulation and startup funding. The event will also feature several one-on-one interviews with CEOs discussing the future of finance.

Other confirmed speakers at the event will include:

  • Walt Bettinger, President and CEO, Charles Schwab
  • Vanessa Colella, Head of Citi Ventures and Chief Innovation Officer, Citi
  • Arthur Levitt, Board Member, Bloomberg
  • Scott Sanborn, CEO, LendingClub
  • Boe Hartman, Chief Technology Officer and Chief Information Officer, Goldman Sachs Bank USA
  • Dan Schulman, President and CEO, PayPal
  • Adena Friedman, President and CEO, Nasdaq
  • Zanny Minton Beddoes, Editor-in-Chief, The Economist

The event is open to the media. Please contact Tylor Tourville (information below) for media registration credentials.

About CTBC Bank Corp. (USA) CTBC Bank USA is a trusted and established institution providing commercial and retail customers with a real financial bridge to the next state of their lives and businesses.  Founded in 1989 and headquartered in Los Angeles, CTBC Bank operates branches in California, New Jersey, and New York. The bank’s operations include deposits, loans, credit cards, foreign exchange, letters of credit, wealth management, mobile, and electronic banking services. Customers benefit from access to large bank resources coupled with individual attention and customized service of a small bank.  Its parent company, CTBC Bank Co. Ltd., is supported by nearly $110 billion in assets and is among the largest banks in the world in terms of capital. For more information about CTBC Bank, visit www.ctbcbankusa.com .

Dan Margolis, for CTBC Bank        +1 (213) 452.6472                                            dan.margolis@fticonsulting.com         

Sean Liao, for Chinese Media  +1 (424) 277-4531  Sean.Liao@ctbcbankusa.com  

Tylor Tourville, for The Economist  +1 (617) 391-0768 Tylor.Tourville@BackBayCommunications.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 1

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 2

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 7

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 3

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 2

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 2

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading

Top 5 Most Recently Viewed Articles

CoreWeave Partners with Nvidia for Advanced AI Development

Updated Category News Views 179

CoreWeave Enhances AI Capabilities CoreWeave, Inc. (NASDAQ: CRWV) has recently announced its plans to integrate advanced technologies from Nvidia Corporation (NASDAQ: NVDA) into its AI cloud platform. This move, which focuses on the incorporation of Nvidia's Rubin technology, aims to propel the capabilities of agentic AI, expand reasoning, and manage large-scale inference...

Continue Reading
Wall Street Adjusts Okta Earnings Forecast for Q3 Results

Updated Category News Views 145

Wall Street Analysts Revise Okta Earnings Predictions Okta, Inc. (NASDAQ: OKTA) is set to announce its earnings results for the third quarter shortly. Analysts are anticipating a significant development in the company's performance, with expectations centered around an increase in earnings per share. Quarterly Earnings Expectations Currently, experts predict that Okta...

Continue Reading
Bausch Health Enhances Financial Flexibility with $400 Million Loan

Updated Category News Views 208

Bausch Health Strengthens Financial Position Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the pharmaceutical industry, has made a significant financial move by securing an amendment to its credit agreement. This amendment allows its subsidiary, Bausch + Lomb Corporation, to access an additional $400 million in term loans, boosting its financial...

Continue Reading
Unicoin Expands Digital Assets Reach with DiamondLake Acquisition

Updated Category News Views 200

Unicoin Expands Digital Asset Treasures through Strategic Acquisition Unicoin Inc., a leader in the digital currency landscape, is excited to share a transformative deal that underlines its commitment to growing the digital asset market. The company has finalized an agreement to acquire a 51% stake in Diamond Lake Minerals Inc. (OTC: DLMI), which is known for pioneering...

Continue Reading
Amneal's New FDA Approvals: Innovations in Pharmaceuticals and Care

Updated Category News Views 381

Amneal Pharmaceuticals Secures Key U.S. FDA Approvals Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) has successfully received approval from the U.S. Food and Drug Administration (FDA) for several important medications designed to improve patient care and meet the needs of various health conditions. This approval marks a significant milestone in the company’s journey to...

Continue Reading